First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Trading 0.6% Higher – Here’s Why

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) was up 0.6% on Monday . The company traded as high as $40.89 and last traded at $40.72. 9,304 shares changed hands during mid-day trading, a decline of 96% from the average session volume of 222,559 shares. The stock had previously closed at $40.47.

First Trust Nasdaq Pharmaceuticals ETF Stock Performance

The stock’s fifty day moving average is $40.07 and its two-hundred day moving average is $36.67. The firm has a market capitalization of $1.05 billion, a price-to-earnings ratio of 14.51 and a beta of 0.46.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Thursday, June 25th were paid a $0.092 dividend. This is a boost from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.06. The ex-dividend date was Thursday, June 25th. This represents a $0.37 dividend on an annualized basis and a dividend yield of 0.9%.

Hedge Funds Weigh In On First Trust Nasdaq Pharmaceuticals ETF

Several large investors have recently added to or reduced their stakes in the company. Compass Financial Management LLC bought a new position in First Trust Nasdaq Pharmaceuticals ETF in the 2nd quarter worth about $29,000. Flputnam Investment Management Co. bought a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the fourth quarter valued at approximately $230,000. Vivaldi Capital Management LP raised its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 16.0% during the first quarter. Vivaldi Capital Management LP now owns 12,590 shares of the company’s stock valued at $433,000 after buying an additional 1,741 shares during the last quarter. Nilsine Partners LLC raised its stake in First Trust Nasdaq Pharmaceuticals ETF by 3.5% during the 2nd quarter. Nilsine Partners LLC now owns 28,057 shares of the company’s stock valued at $1,071,000 after acquiring an additional 937 shares in the last quarter. Finally, Marshall Investment Management LLC acquired a new position in First Trust Nasdaq Pharmaceuticals ETF during the 4th quarter worth $1,377,000.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.